Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (211-220 of 437) with videos related to

Pageof 44
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
The Oncologist|May 10, 2020
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.SAshley A Leech, Peter J Neumann, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of ImplicationsPeter J Neumann, Meghan I Podolsky, Anirban Basu, et al.
Pharmacoeconomics|July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation StudyPei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Health Affairs (Project Hope)|November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower CostsKatherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
BMC Nephrology|May 1, 2015
Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS studyKeri L Monda, Parveen Nedra Joseph, Peter J Neumann, et al.
Applied Health Economics and Health Policy|November 25, 2021
Are Medical Devices Cost-Effective?James D Chambers, Madison C Silver, Flora C Berklein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical ProceduresJames Chambers, Elle Pope, Kathy Bungay, et al.
Journal of Managed Care Pharmacy : JMCP|March 31, 2009
Standardizing quality assessment of observational studies for decision making in health careDiana I Brixner, Anke-Peggy Holtorf, Peter J Neumann, et al.
Pageof 44

Showing results (211-220 of 437) with videos related to

Sort By:
Pageof 44
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
The Oncologist|May 10, 2020
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.SAshley A Leech, Peter J Neumann, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of ImplicationsPeter J Neumann, Meghan I Podolsky, Anirban Basu, et al.
Pharmacoeconomics|July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation StudyPei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Health Affairs (Project Hope)|November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower CostsKatherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
BMC Nephrology|May 1, 2015
Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS studyKeri L Monda, Parveen Nedra Joseph, Peter J Neumann, et al.
Applied Health Economics and Health Policy|November 25, 2021
Are Medical Devices Cost-Effective?James D Chambers, Madison C Silver, Flora C Berklein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical ProceduresJames Chambers, Elle Pope, Kathy Bungay, et al.
Journal of Managed Care Pharmacy : JMCP|March 31, 2009
Standardizing quality assessment of observational studies for decision making in health careDiana I Brixner, Anke-Peggy Holtorf, Peter J Neumann, et al.
Pageof 44